文献速递免疫规划传染病防控与疫情报告卫生政策与健康促进

波多黎各COVID-19疫苗可及前后登革热疫苗接受度

Dengue vaccine acceptability before and after the availability of COVID-19 vaccines in Puerto Rico.
PubMed 文献 · Vaccine · 2023-05-05

研究基于COPA队列,比较COVID-19疫苗可及前后波多黎各居民登革热疫苗接种意愿变化。COVID-19后成人自身接种意愿从73.4%升至84.5%(aOR=2.27,95%CI:1.90-2.71),为儿童接种意愿从75.6%升至85.5%(aOR=2.21,95%CI:1.75-2.78)。主要犹豫原因为担心副作用和不相信疫苗。

要点

  • COVID-19疫苗可及后,成人自身及为儿童接种登革热疫苗意愿均升高。
  • 既往年流感疫苗接种者和常被蚊虫叮咬者登革热疫苗接种意愿更高。
  • 疫苗犹豫主要因担心副作用和不相信疫苗,应纳入教育策略。

核心结论

  • 波多黎各登革热疫苗接种意愿总体较高,且在COVID-19疫苗可及后有所增加,可能因疫情期间疫苗重要性认知提升。

研究设计与样本

  • 基于Communities Organized to Prevent Arboviruses(COPA)队列,采用逻辑回归模型评估登革热疫苗接种意愿随访谈时间和参与者特征的变化。
  • COVID-19前共2513名参与者,其中2512人回答自身接种意愿问题,1564人回答为子女接种意愿问题。

主要发现

  • COVID-19后成人自身登革热疫苗接种意愿从73.4%升至84.5%(aOR=2.27,95%CI:1.90-2.71)。
  • COVID-19后成人为子女接种登革热疫苗意愿从75.6%升至85.5%(aOR=2.21,95%CI:1.75-2.78)。
  • 报告既往年接种流感疫苗者和报告常被蚊虫叮咬者,登革热疫苗接种意愿高于无相应报告者。
  • 成年男性自身接种登革热疫苗意愿高于女性。
  • 在职或在校受访者接种意愿低于未工作者。

关键数值与推荐

  • 2021年6月,免疫实践咨询委员会(ACIP)推荐首个登革热疫苗(CYD-TDV)用于9-16岁、有既往登革热感染史且居住在流行地区(如波多黎各)的儿童。
  • 疫苗犹豫主要原因为担心副作用和不相信疫苗。

临床怎么用

  • 在登革热疫苗实施前,教育策略应考虑对副作用担忧和不相信疫苗的犹豫原因。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Dengue is a growing public health threat, causing approximately 400 million infections annually. In June 2021, the Advisory Committee on Immunization Practices recommended the first dengue vaccine (CYD-TDV) for children aged 9-16 years with a previous dengue infection, living in endemic areas, such as Puerto Rico (PR). As the COVID-19 pandemic affected vaccine intention worldwide, we assessed dengue vaccine intention before (pre-COVID) and after (post-COVID) COVID-19 vaccine availability among participants enrolled in the Communities Organized to Prevent Arboviruses (COPA) cohort to prepare for dengue vaccine implementation in PR. We used logistic regression models to evaluate changes in dengue vaccine intention by interview timing and participant characteristics. Among 2,513 participants pre-COVID, 2,512 answered the dengue vaccine intention question for themselves, and 1,564 answered relative to their children. Post-COVID, dengue vaccine intention in adults increased for themselves from 73.4% to 84.5% (adjusted odds ratio (aOR) = 2.27, 95%CI: 1.90-2.71) and relative to their children from 75.6% to 85.5% (aOR = 2.21, 95%CI: 1.75-2.78). Among all participants, groups with higher dengue vaccine intention included those who reported previous year influenza vaccine uptake and those who reported being frequently bitten by mosquitos, compared to those who did not. Adult males were also more likely to intend to vaccinate themselves than females. Respondents who were employed or in school were less likely to intend to vaccinate compared to those who were not working. The primary reasons for vaccine hesitancy were concerns with side effects and not believing in vaccines, which should be considered during educational strategies prior to dengue vaccine implementation. In general, dengue vaccine intention is high in PR and has increased after COVID-19 vaccine availability, potentially due to increased awareness of vaccine importance during the COVID-19 pandemic.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Rodriguez DM, Major CG, Sánchez-González L, et al. Dengue vaccine acceptability before and after the availability of COVID-19 vaccines in Puerto Rico. Vaccine. 2023. PMID: 37173267. doi:10.1016/j.vaccine.2023.04.081

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。